randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology Acetyl-l-carnitine versus placebo for migraine
Acetyl l carnitine versus placebo for migraine prophylaxis: A randomized, triple blind, crossover study Knut Hagen, Eiliv Brenner, Mattias Linde, Gril Bruvik Gravdahl, Erling Andreas Tronvik, Morten Engstrm, Ursula Sonnewald, Grethe Helde, Lars Jacob Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double blinded placebo controlled trial ScienceDirect A Multicenter, Randomized, Double blind, Placebo controlled Clinical Trial for Efficacy of Acetyl L carnitine in Patients with Dementia Associated with Cerebrovascular Disease PMC
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

00262-4/asset/89dd934c-f271-4a89-9f55-b9a4707e82c0/main.assets/gr3_lrg.jpg)

